{"database": "openregs", "table": "documents", "rows": [["FDA-2009-P-0597-0032", "FDA", "FDA-2009-P-0597", "Interim Response to GlaxoSmithKline (Ropes & Gray LLP)", "Other", "LET-Letter", "2010-06-09T04:00:00Z", 2010, 6, "2010-06-09T04:00:00Z", null, "2013-08-11T04:40:18Z", null, 0, 0, "0900006480afef88"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2009-P-0597-0032"], "units": {}, "query_ms": 0.4788211081176996, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}